Search research articles
Contact Us
Filters
Showing results (21-30 of 52) with videos related to
Page
of 6
Sort By:
Alimentary Pharmacology & Therapeutics
|
March 25, 2006
Patients with irritable bowel syndrome in primary care appear not to be heavy healthcare utilizers
A Faresjö, E Grodzinsky, M Foldevi, et al.
Gut
|
April 16, 2005
Epidemiology of gastro-oesophageal reflux disease: a systematic review
J Dent, H B El-Serag, M-A Wallander, et al.
Alimentary Pharmacology & Therapeutics
|
September 1, 1999
One-year follow-up of newly diagnosed irritable bowel syndrome patients
A Ruigómez, M A Wallander, S Johansson, et al.
The Annals of Pharmacotherapy
|
September 28, 2001
Prescription drug use, diagnoses, and healthcare utilization among the elderly
T Jörgensen, S Johansson, A Kennerfalk, et al.
Pharmacoepidemiology and Drug Safety
|
July 1, 1997
Renal disease and acid-suppressing drugs
L A García Rodríguez, M A Wallander, S Johanson, et al.
Alimentary Pharmacology & Therapeutics
|
April 23, 2002
Extra-intestinal manifestations associated with irritable bowel syndrome: a twin study
P Svedberg, S Johansson, M-A Wallander, et al.
Alimentary Pharmacology & Therapeutics
|
August 16, 2005
Risk factors for inflammatory bowel disease in the general population
L A García Rodríguez, A González-Pérez, S Johansson, et al.
Digestion
|
January 1, 1992
Safety experience from long-term treatment with omeprazole
S Joelson, I B Joelson, P Lundborg, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
October 15, 2013
Use of prescription contraceptive methods in the UK general population: a primary care study
L Cea-Soriano, L A García Rodríguez, A Machlitt, et al.
Journal of Epidemiology and Community Health
|
March 15, 2000
Overall mortality among patients surviving an episode of peptic ulcer bleeding
A Ruigómez, L A García Rodríguez, G Hasselgren, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 52) with videos related to
Sort By:
Page
of 6
Alimentary Pharmacology & Therapeutics
|
March 25, 2006
Patients with irritable bowel syndrome in primary care appear not to be heavy healthcare utilizers
A Faresjö, E Grodzinsky, M Foldevi, et al.
Gut
|
April 16, 2005
Epidemiology of gastro-oesophageal reflux disease: a systematic review
J Dent, H B El-Serag, M-A Wallander, et al.
Alimentary Pharmacology & Therapeutics
|
September 1, 1999
One-year follow-up of newly diagnosed irritable bowel syndrome patients
A Ruigómez, M A Wallander, S Johansson, et al.
The Annals of Pharmacotherapy
|
September 28, 2001
Prescription drug use, diagnoses, and healthcare utilization among the elderly
T Jörgensen, S Johansson, A Kennerfalk, et al.
Pharmacoepidemiology and Drug Safety
|
July 1, 1997
Renal disease and acid-suppressing drugs
L A García Rodríguez, M A Wallander, S Johanson, et al.
Alimentary Pharmacology & Therapeutics
|
April 23, 2002
Extra-intestinal manifestations associated with irritable bowel syndrome: a twin study
P Svedberg, S Johansson, M-A Wallander, et al.
Alimentary Pharmacology & Therapeutics
|
August 16, 2005
Risk factors for inflammatory bowel disease in the general population
L A García Rodríguez, A González-Pérez, S Johansson, et al.
Digestion
|
January 1, 1992
Safety experience from long-term treatment with omeprazole
S Joelson, I B Joelson, P Lundborg, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
October 15, 2013
Use of prescription contraceptive methods in the UK general population: a primary care study
L Cea-Soriano, L A García Rodríguez, A Machlitt, et al.
Journal of Epidemiology and Community Health
|
March 15, 2000
Overall mortality among patients surviving an episode of peptic ulcer bleeding
A Ruigómez, L A García Rodríguez, G Hasselgren, et al.
Page
of 6